ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 639186 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 639186; 2) Community: the network communities that were significantly associated with the response to NSC 639186; 3) Molecule: the relationships between components within communities and NSC 639186; 4) MDR: the compounds that were significantly associated with the NSC 639186.

NSC Compound Enrichment Correlation
NSC 744469 3-cyano-3,3-diphenylpropyl 4-(3-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropyl)-1-piperazinecarbodithioate 0.0133299224082802 0.40954361
NSC 758359 N3-[1-(3-phenoxybenzyl)-1H-1,2,3-triazol-4-yl]methyl-2-(4-fluoroanilino)nicotinamide 0.0133299224082802 -0.037370855
NSC 95466 PCNU 0.0133299224082802 0.5442206
NSC 104801 Cytembena 0.0133299224082803 0.21536181
NSC 13484 Null 0.0133299224082803 0.24343378
NSC 176323 Camptothecin Derivative 0.0133299224082803 0.47287526
NSC 178248 Chlorozotocin 0.0133299224082803 0.52724373
NSC 374980 Acetamide, N-[2,3-bis(acetyloxy)-5,6,7,9-tetrahydro-1-methoxy-10-(methylthio)-9-oxobenzo[a]heptalen-7-yl]-, (S)- 0.0133299224082803 0.089292044
NSC 624191 Null 0.0133299224082803 0.31862547
NSC 628949 Null 0.0133299224082803 0.25197891
Total:83  Current:34    [First] [Prev] [Next] [Last]